In human HCC, TTP is downregulated at the protein level, and we could show using transgenic mouse models that TTP displays a dual oncogenic and tumor-suppressive role depending on the stage of the disease [125,128]. This evidence concerns the gene ZFP36 and hepatocellular carcinoma.